Simple jQuery Dropdowns

Browsing by Author Jun Zhu

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
5-Jun-2017Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study<sup>*</sup>Tadeusz Robak; Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Juliana Pereira; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi van de Velde; Franco Cavalli; Medical University of Lodz; Sun Yat-Sen University Cancer Center; Zhejiang University School of Medicine; Beijing Cancer Hospital; West China Hospital of Sichuan University; Lobachevsky State University of Nizhni Novgorod; null; KU Leuven– University Hospital Leuven; Mahidol University; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; Universidade de Sao Paulo - USP; Fakultni Nemocnice Brno; Fudan University Shanghai Cancer Center; Tokyo Metropolitan Komagome Hospital; Janssen; Janssen Research and Development; Takeda Oncology; Ospedale San Giovanni
5-Mar-2015Bortezomib-based therapy for newly diagnosed mantle-cell lymphomaTadeusz Robak; Huiqiang Huang; Jie Jin; Jun Zhu; Ting Liu; Olga Samoilova; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Evgenii Osmanov; Julia Alexeeva; Juliana Pereira; Johannes Drach; Jiri Mayer; Xiaonan Hong; Rumiko Okamoto; Lixia Pei; Brendan Rooney; Helgi Van De Velde; Franco Cavalli; Medical University of Lodz; Sun Yat-Sen University Cancer Center; Zhejiang University School of Medicine; Beijing Cancer Hospital; West China Hospital of Sichuan University; Fudan University Shanghai Cancer Center; Nizhny Novgorod Regional Hospital; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; Federal Center of Heart; Cherkassy Regional Oncology Center; KU Leuven– University Hospital Leuven; Janssen Research and Development; Mahidol University; Universidade de Sao Paulo - USP; Medizinische Universitat Wien; Fakultni Nemocnice Brno; Tokyo Metropolitan Komagome Hospital; Janssen; Janssen Research and Development; Ospedale San Giovanni
1-Jul-2013Dabigatran versus warfarin: Effects on ischemic and hemorrhagic strokes and bleeding in asians and non-Asians with atrial fibrillationMasatsugu Hori; Stuart J. Connolly; Jun Zhu; Li Sheng Liu; Chu Pak Lau; Prem Pais; Denis Xavier; Sung Soon Kim; Razali Omar; Antonio L. Dans; Ru San Tan; Jyh Hong Chen; Supachai Tanomsup; Mitsunori Watanabe; Masahide Koyanagi; Michael D. Ezekowitz; Paul A. Reilly; Lars Wallentin; Salim Yusuf; Osaka Medical Center for Cancer and Cardiovascular Diseases; Population Health Research Institute, Ontario; Fuwai Hospital; The University of Hong Kong; Research Institute; Yonsei University College of Medicine; Institut Jantung Negara Kuala Lumpur; Philippine General Hospital; National Heart Centre, Singapore; National Cheng Kung University Hospital; Mahidol University; Nippon Boehringer Ingelheim Co., Ltd.; Jefferson Medical College; Boehringer Ingelheim Pharmaceuticals, Inc.; Akademiska Sjukhuset
1-Nov-2018Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 studyTadeusz Robak; Jie Jin; Halyna Pylypenko; Gregor Verhoef; Noppadol Siritanaratkul; Johannes Drach; Markus Raderer; Jiri Mayer; Juliana Pereira; Gayane Tumyan; Rumiko Okamoto; Susumu Nakahara; Peter Hu; Carlos Appiani; Sepideh Nemat; Franco Cavalli; Achiel Van Hoof; Adriana Sheliga; Adriana Teixeira; Akihiro Tomita; Albert Oriol Rocafiguera; Alexander Suvorov; Alexy Kuzmin; Ali Khojasteh; Amel Mezlini; Anatoly Golenkov; Andre Bosly; Andrew Belch; Ann Van De Velde; Árpád Illes; Ashis Mukhopadhyay; Balkis Meddeb; Bernard De Prijck; Bernardo Garichochea; Bulent Undar; Caballero Gabarrón; Carmen Cao; Carmino Souza; Charles Farber; Cheol Won Suh; Cristina Ileana Burcoveanu; Cristina Ligia Cebotaru; Cristina Ligia Truica; Dai Maruyama; David Belada; Dina Ben Yehuda; Dmitry Udovitsa; Dolores; Enrica Morra; Ernst Späth-Schwalbe; Eva Gonzalez-Barca; Evgenii Osmanov; Francisco Javier Capote; Fritz Offner; Galvez Cardenas; Georg Heß; Georgii Manikhas; Govind Babu; Grigoriy Rekhtman; Guiseppe Rossi; Herlander Marques; Horia Bumbea; Huaqing Wang; Huiqiang Huang; Ilseung Choi; Irina Bulavina; Irina Lysenko; Irit Avivi; Iryna Kryachok; Jan Maciej Zaucha; Jan Novak; Joaquín Díaz; Judit Demeter; Julia Alexeeva; Jun Zhu; Kateryna Vilchevskaya; Kenichi Ishizawa; Kenny Mauricio; Kensei Tobinai; Kiyoshi Ando; Kudrat Abdulkadryrov; Lee Yung Shih; Lyudmila Kuzina; Mahmut Gumus; Maike De Wit; Marcelo Capra; Margarida Marques; Marina Golubeva; Mario Ojeda-Uribe; Maryna Kyselyova; Masafumi Taniwaki; Massimo Federico; Michael Crump; Michele Baccarani; Michinori Ogura; Miklós Egyed; Miklos Udvardy; Mitsutoshi Kurosawa; Naokuni Uike; Nuriet Khuageva; The First Affiliated Hospital, Zhejiang University School of Medicine; Cherkassy Regional Oncology Center; Janssen Research &amp; Development; N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences; KU Leuven– University Hospital Leuven; Masaryk University; Janssen; Allgemeines KrankenHaus Wien; Ospedale San Giovanni; Medizinische Universitat Wien; Faculty of Medicine, Siriraj Hospital, Mahidol University; Universidade de Sao Paulo - USP; Medical University of Lodz; Janssen Pharmaceutical; Chibanishi General Hospital
16-Jul-2013The long-term multicenter observational study of dabigatran treatment in patients with atrial fibrillation (RELY-ABLE) studyStuart J. Connolly; Lars Wallentin; Michael D. Ezekowitz; John Eikelboom; Jonas Oldgren; Paul A. Reilly; Martina Brueckmann; Janice Pogue; Marco Alings; John V. Amerena; Alvaro Avezum; Iris Baumgartner; Andrzej J. Budaj; Jyh Hong Chen; Antonio L. Dans; Harald Darius; Giuseppe Di Pasquale; Jorge Ferreira; Greg C. Flaker; Marcus D. Flather; Maria Grazia Franzosi; Sergey P. Golitsyn; David A. Halon; Hein Heidbuchel; Stefan H. Hohnloser; Kurt Huber; Petr Jansky; Gabriel Kamensky; Matyas Keltai; Sung Soon Kim; Chu Pak Lau; Jean Yves Le Heuzey; Basil S. Lewis; Lisheng Liu; John Nanas; Razali Omar; Prem Pais; Knud E. Pedersen; Leopoldo S. Piegas; Dimitar Raev; Pal J. Smith; Mario Talajic; Ru San Tan; Supachai Tanomsup; Lauri Toivonen; Dragos Vinereanu; Denis Xavier; Jun Zhu; Susan Q. Wang; Christine O. Duffy; Ellison Themeles; Salim Yusuf; Population Health Research Institute, Ontario; Akademiska Sjukhuset; Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH &amp; Co. KG; Universitat Heidelberg; Amphia Hospital; Deakin University; Instituto Dante Pazzanese de Cardiologia; Swiss Cardiovascular Center, University Hospital Bern; Szpital Grochowski, Warszawa; National Cheng Kung University; University of the Philippines Manila; Vivantes Neukoelln Medical Center; Ospedale Maggiore; Lankenau Institute for Medical Research; Hospital de Santa Cruz, Carnaxide; University of Missouri-Columbia; Royal Brompton Hospital; Istituto di Ricerche Farmacologiche Mario Negri; National Medical Research Center of Cardiology, Moscow; Carmel Medical Center; KU Leuven; Goethe-Universitat Frankfurt am Main; Wiener Krakenanstaltenverbund; Fakultni Nemocnice v Motole; University Hospital in Bratislava; Semmelweis Egyetem; Yonsei University College of Medicine; The University of Hong Kong; Universite Paris Descartes; Fuwai Hospital; University of Athens; Institut Jantung Negara Kuala Lumpur; St. John's Medical College; Odense Universitetshospital; Ministry of Interior; Akershus University Hospital; Institut de Cardiologie de Montreal; National Heart Centre, Singapore; Mahidol University; Helsinki University Hospital; Universitatea de Medicina si Farmacie Carol Davila din Bucuresti